Product Information
CLONAZEPAM 2 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0378 per EA under NDC 00093321305. Its NADAC has been published 346 times since Nov 13, 2019.
Strength
2 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093321305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA074569On Market Since
9/18/1996
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 2 MG TABLET has been published 346 times since Nov 13, 2019, and over the history we have for it it has declined 7.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0378 per EA |
|---|---|
| All-time high | $0.0478 (Apr 15, 2020) |
| All-time low | $0.0316 (Nov 20, 2024) |
| 52-week high | $0.0436 |
| 52-week low | $0.0378 |
| Median price | $0.0395 |
| Average price | $0.0396 |
| Largest weekly change | -28.0% (Nov 20, 2024) |
| Weeks tracked | 346 |
| Tracking since | Nov 13, 2019 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 2 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0378 per EA (NDC 00093321305), effective Jun 24, 2026.
How has the price of CLONAZEPAM 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 2 MG TABLET has declined 7.3%. It has been tracked across 346 weekly CMS publications since Nov 13, 2019.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 2 MG TABLET?
Since Nov 13, 2019, the NADAC for CLONAZEPAM 2 MG TABLET has ranged from a low of $0.0316 (Nov 20, 2024) to a high of $0.0478 (Apr 15, 2020), with a median of $0.0395 per EA.
Are there cheaper alternatives to CLONAZEPAM 2 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as CLONAZEPAM 2 MG TABLET, but none are currently priced below it.
Who manufactures CLONAZEPAM 2 MG TABLET?
CLONAZEPAM 2 MG TABLET (NDC 00093321305) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification